angiotensin ii has been researched along with lactoferrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rexroad, CE; Womack, JE; Yang, Y | 1 |
| Badimon, L; Costales, P; Huesca-Gómez, C; Llorente-Cortés, V; Sendra, J | 1 |
| Arce, C; Castelló-Ruiz, M; Fernández-Musoles, R; Ivorra, MD; Manzanares, P; Salom, JB | 1 |
| Chen, W; Fang, H; Gao, Y; Luo, M; Shen, Y | 1 |
4 other study(ies) available for angiotensin ii and lactoferrin
| Article | Year |
|---|---|
Use of the human transcript map to assign five loci to bovine chromosomes.
Topics: Angiotensin II; Animals; Cattle; Chromosome Mapping; Cytoskeletal Proteins; DNA Primers; Expressed Sequence Tags; Genetic Markers; Humans; Lactoferrin; Monosaccharide Transport Proteins; Phosphoproteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Purinergic P2 | 1999 |
Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Cholesterol Esters; Disease Models, Animal; Humans; Hypertension; Imidazoles; Lactoferrin; Losartan; Low Density Lipoprotein Receptor-Related Protein-1; Male; Muscle, Smooth, Vascular; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Up-Regulation | 2008 |
Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Hypertension; Lactoferrin; Male; Molecular Weight; Peptides; Rabbits; Receptor, Angiotensin, Type 1; Vasoconstriction | 2014 |
Molecular mechanisms associated with Angiotensin-converting enzyme-inhibitory peptide activity on vascular extracellular matrix remodeling.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Carotid Artery, Common; Collagen; Elastic Tissue; Extracellular Matrix; Heart Rate; Inflammation; Lactoferrin; Laminin; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Peptide Fragments; Random Allocation; Rats; Rats, Inbred SHR; Transcription Factor RelA; Transforming Growth Factor beta1 | 2014 |